Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: Results of a double-blind, randomized, placeb... von Krupashankar, D.S., MD, DVD, MISD, FAAD, Dogra, Sunil, MD, DNB, FRCP (London), Kura, Mahendra, MD, DNB, Saraswat, Abir, MD, DNB, MNAMS, Budamakuntla, Leelavathy, MD, Sumathy, T.K., MD, DNB, Shah, Radha, MD, FCPS, DDV (Bom), Gopal, M.G., MD, Narayana Rao, T., MD, DD, Srinivas, C.R., MD, Bhat, Ramesh, MD, DNB, DVD, Shetty, Narendra, MD, Manmohan, G., MD, DD, Sai Krishna, Kotla, MD, DD, Padmaja, Dalavoi, MD, Pratap, Dasiga Venkata Subrahmanya, MD, DD, Garg, Vijay, MD, Gupta, Sandesh, DVD, MCSA, Pandey, Neeraj, MD, Khopkar, Uday, DVD, MD, DNB, Montero, Enrique, MD, PhD, Ramakrishnan, M.S., PhD, Nair, Pradip, PhD, Ganapathi, Prasanna C., MD

Volltext

Long-term efficacy and safety of itolizumab in patients with moderate-to-severe chronic plaque psoriasis: A double-blind, randomized-withdrawal, placebo-controlled study von Dogra, Sunil, MD, DNB, FRCP (London), D.S., Krupashankar, MD, DVD, MISD, FAAD, Budamakuntla, Leelavathy, MD, Srinivas, C.R., MD, Khopkar, Uday, DVD, MD, DNB, Gupta, Sandesh, DVD, MCSA, Shetty, Narendra, MD, Pratap, Dasiga Venkata Subrahmanya, MD, DD, Gopal, M.G., MD, Rao, T. Narayana, MD, DD, Garg, Vijay, MD, Sumathy, T.K., MD, DNB, Saraswat, Abir, MD, DNB, MNAMS, Bhat, Ramesh, MD, DNB, DVD, Kura, Mahendra, MD, DNB, Pandey, Neeraj, MD, Shah, Radha, MD, FCPS, DDV (Bom), Sai Krishna, Kotla, MD, DD, Padmaja, Dalavai, MD, Manmohan, G., MD, DD, M.S., Ramakrishnan, PhD, Barve, Abhijit, MD, PhD, Montero, Enrique, MD, PhD

Volltext

Evaluation of efficacy, safety, and tolerability of fixed dose combination (FDC) of halometasone 0.05% and fusidic acid 2% w/w topical cream versus FDC of betamethasone valerate 0.... von Pratap, Dasiga, Philip, Mariam, Rao, Narayana, Jerajani, Hemangi, Kumar, Sainath, Kuruvila, Maria, Moodahadu, Latha, Dhawan, Shilpi

Volltext